Flow cytometric minimal residual disease as risk stratification tool in younger adults with npm1 wild type standard risk acute myeloid leukemia

Category Primary study
JournalBlood
Year 2017
This article has no abstract
Epistemonikos ID: e46fbbdb83205d40a399ee7c0b980fd0d27983b6
First added on: Feb 08, 2025